Now showing items 1-1 of 1
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
(2017-08-29) - Journal article,
Emerging data demonstrate homologous recombination (HR) defects in castration-resistant prostate cancers, rendering these tumours sensitive to PARP inhibition. Here we demonstrate a direct requirement for the androgen ...